Global Botulinum Toxin A Market Growth (Status and Outlook) 2023-2029

Global Botulinum Toxin A Market Growth (Status and Outlook) 2023-2029

Botulinum toxin is the bacterial toxin secreted by the deadly botulinum toxin, action on the end of the cholinergic nerve, antagonism calcium ion, interference acetylcholine release, make muscle fiber cannot contract cause muscle relaxation, achieve the purpose of wrinkle beauty.Botox was first used as a biological weapon, and was later used by the medical community to treat facial cramps and other muscle-movement disorders. In the 1980s, the plastic surgery community expanded its function, using it to thin the face and shape the legs.China is the third country after the United Kingdom and the United States to produce its own botox cosmetic products, and began to use in 1999.In recent years, global botulinum toxin type A has developed rapidly, with an average growth rate of about 15%. In 2017, global production of botulinum toxin type A was 22.35 million bottles, with an output value of $4 billion.The price of botulinum toxin type A has been on A downward trend due to the economic environment, the improvement of people's health level and the influx of low-end products into the market, with the price dropping from $194 / bottle in 2013 to $178 / bottle in 2017.We expect prices to continue to fall over the next few years as domestic players get bigger and stronger and new products emerge.There are three main types of botulinum toxin A products: 50 units, 100 units and others.Of these, 50 units accounted for the largest share, accounting for 59% of the market in 2017.Botulinum toxin A is used mainly for medical and cosmetic purposes.Medical use accounted for the majority, accounting for about 51% of the total market in 2017.The United States is the top sales region, accounting for 54 percent of global sales in 2017.In 2017, China accounted for 5 percent of global production, while China accounted for 9 percent of global sales. China is an importer.North America is also a major consumer region, but due to the high development level in these regions, the annual growth rate is relatively flat. Currently, there are only two kinds of botox approved in China, namely the balance of lanzhou institute of biological products and the protection of allergan, which have not changed in recent years.Due to the larger dispersion, it is suitable for the injection of larger muscles and itself, such as thin face, thin leg, and the cost of weight is cheap, cost-effective;However, the dispersivity of propofol is small, which is suitable for accurate injection such as wrinkle removal.At present, allergan, ipson, Merz Pharmaceuticals, Medytox, lanzhou hengli and other industrial giants represented by the products occupy the mainstream position in the international market.
LPI (LP Information)' newest research report, the “Botulinum Toxin A Industry Forecast” looks at past sales and reviews total world Botulinum Toxin A sales in 2022, providing a comprehensive analysis by region and market sector of projected Botulinum Toxin A sales for 2023 through 2029. With Botulinum Toxin A sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Botulinum Toxin A industry.
This Insight Report provides a comprehensive analysis of the global Botulinum Toxin A landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Botulinum Toxin A portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Botulinum Toxin A market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Botulinum Toxin A and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Botulinum Toxin A.
The global Botulinum Toxin A market size is projected to grow from US$ 6420.6 million in 2022 to US$ 15770 million in 2029; it is expected to grow at a CAGR of 13.7% from 2023 to 2029.
Global Botulinum Toxin A key players include Allergan (AGN), Ipsen, Merz Pharmaceuticals, etc.
United States is the largest market, with a share about 75%, followed by China, and Europe, both have a share about 20 percent.
In terms of product, 50iu is the largest segment, with a share about 60%. And in terms of application, the largest application is Medical Use, followed by Beauty Use.
This report presents a comprehensive overview, market shares, and growth opportunities of Botulinum Toxin A market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
50iu
100iu
Other
Segmentation by application
Medical Use
Beauty Use
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Allergan (AGN)
Ipsen
Merz Pharmaceuticals
Medytox
BTXA

Please note: The report will take approximately 2 business days to prepare and deliver.